CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug AST-201 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new drug called AST-201 in about 70 adults with advanced solid tumors that have a specific protein (GPC3). The main goal is to check the drug's safety and find the right dose. Researchers will also look at how the drug moves through the body and whe…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE1 • Sponsor: Aptamer Sciences, Inc. • Aim: Disease control
Last updated May 17, 2026 00:48 UTC
-
Liver cancer trial adds immunotherapy after standard treatment
Disease control Recruiting nowThis study tests whether adding the drug tislelizumab after standard local therapy (like radiation) can help control advanced liver cancer that cannot be surgically removed. The goal is to improve the time patients live without their cancer getting worse. About 35 adults with liv…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New combo attack shrinks untreatable liver tumors?
Disease control Recruiting nowThis study tests a powerful mix of treatments for people with advanced liver cancer that cannot be surgically removed. The approach combines tumor destruction (ablation), targeted therapy (lenvatinib), immunotherapy (tislelizumab), and a procedure that blocks the tumor's blood su…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New hope for liver cancer: pfizer launches drug combo trial
Disease control Recruiting nowThis study tests a new medicine called PF-08634404, given alone or with another drug (ipilimumab), for adults with advanced liver cancer that cannot be removed by surgery. The goal is to check safety and see if the treatment shrinks tumors. About 138 participants will receive the…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New Triple-Drug attack on liver cancer shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called Irpagratinib combined with two existing cancer drugs (Atezolizumab and Bevacizumab) for people with advanced liver cancer that cannot be removed by surgery. The goal is to see if the combination is safe and shrinks tumors. About 33 adults with a…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Could a better scan slash liver cancer deaths? major VA trial launches
Diagnosis Recruiting nowThis study tests whether a faster MRI scan (aMRI) plus a blood test (AFP) can find liver cancer earlier than the usual ultrasound plus AFP in 4,700 people with cirrhosis. The goal is to catch tumors at an early, more treatable stage and ultimately reduce deaths from liver cancer.…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Diagnosis
Last updated May 17, 2026 01:02 UTC
-
New trial aims to catch liver cancer earlier in thousands at risk
Prevention Recruiting nowThis study tests whether a blood test (GALAD) is better than ultrasound for finding liver cancer early in 5500 people with cirrhosis or chronic hepatitis B. Participants will be randomly assigned to one of two screening methods every six months. The goal is to see which approach …
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated May 14, 2026 12:02 UTC
-
New study aims to uncover how liver cancer affects older patients
Knowledge-focused Recruiting nowThis study looks at how advanced liver cancer behaves and is treated in people aged 65 and older. Researchers will track 84 participants to understand disease patterns, treatment side effects, and aging-related factors. The goal is to improve care for this group by gathering real…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated May 17, 2026 01:03 UTC